4D Molecular Therapeutics to Spotlight at Cystic Fibrosis Event
4D Molecular Therapeutics Highlights Their Presence at 2024 Cystic Fibrosis Conference
EMERYVILLE, Calif. – 4D Molecular Therapeutics (NASDAQ: FDMT), a pioneering company in the realm of genetic medicines, is gearing up for a significant presentation at the upcoming 2024 North American Cystic Fibrosis Conference (NACFC). This event is set to take place in Boston, where 4DMT will showcase its latest advancements from September 26-28.
Details of the 2024 NACFC Presentation
4DMT is excited to announce its captivating poster presentation titled "Transgene expression and CFTR channel function in human bronchial epithelial cells following addition of CFTR modulators and 4D-710." This presentation promises to delve deep into innovations that could enhance treatment approaches for cystic fibrosis.
Poster Session Information
The team's poster will be featured in Poster Session 344. Attendees are encouraged to schedule a visit to learn more about 4D Molecular Therapeutics' groundbreaking work.
When to Catch the Presentation
Mark your calendars for Friday, September 27, 2024, from 1:15 – 2:15 p.m. ET. The 4DMT team, led by Dr. Melissa A. Calton, VP of Early-Stage Product Development, will be on hand to discuss the findings and answer questions.
About 4D Molecular Therapeutics
4DMT specializes in advancing clinical-stage genetic medicines, addressing complex diseases in pivotal areas such as ophthalmology and pulmonology. At the heart of their innovation lies the Therapeutic Vector Evolution platform, a state-of-the-art method incorporating directed evolution technology. This approach utilizes approximately one billion synthetic AAV capsid-derived sequences to engineer customized vectors aimed at enhancing treatment efficacy.
Innovative Product Pipeline
With a robust pipeline that includes six clinical-stage and one preclinical product candidate, 4DMT is developing therapies tailored for both rare and prevalent diseases across several medical fields, including cardiology and central nervous system disorders.
Commitment to Progress
The company is ardently committed to revolutionizing medicine with potentially curative therapies. Their continuous advancements represent a beacon of hope for millions grappling with genetic disorders.
Company Vision and Future Directions
4DMT’s drive is not only to create effective therapies but to ensure they reach the patients who need them most. Their ongoing research and development efforts aim to bring innovative and effective treatments to market, providing long-term solutions for various diseases associated with genetic factors.
Contact Information
For further inquiries, please reach out to:
Media Contact:
Katherine Smith
Inizio Evoke Comms
Media@4DMT.com
Investor Relations:
Julian Pei
Head of Investor Relations and Corporate Finance
Investor.Relations@4DMT.com
Frequently Asked Questions
What is the focus of 4D Molecular Therapeutics?
4DMT is dedicated to developing genetic medicines for various diseases, particularly in ophthalmology and pulmonology.
When and where is 4DMT presenting?
4DMT will present at the 2024 North American Cystic Fibrosis Conference from September 26-28 in Boston.
What is the title of 4DMT's presentation?
The presentation is titled "Transgene expression and CFTR channel function in human bronchial epithelial cells following addition of CFTR modulators and 4D-710."
Who will be presenting at the conference?
The presentation will be delivered by Dr. Melissa A. Calton, the VP of Early-Stage Product Development at 4DMT.
How can I learn more about 4DMT?
You can visit 4D Molecular Therapeutics’ website for more information about their projects, news, and advancements.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- OpenAI's Exciting Shift to Profit: What's Next for Altman?
- Viomi Investor Day Highlights Innovations in AI Water Solutions
- F&M Bank's Golf Classics Gather $53,000 for Local Causes
- Hyliion Stock Rises with Renewable Energy Strategy Update
- Alaska Permanent Fund Corporation Board Meeting Highlights
- Important Shareholder Information Regarding Metagenomi, Inc. (MGX)
- Merck's Market Movements: Insights into Its Stock Performance
- Investing Insights: Stock Opportunities After Rate Cuts
- National Symphony Orchestra Faces Critical Strike Amid Gala
- Highlights and Innovations from the NANOscientific Symposium 2024
Recent Articles
- AAR Secures Major Contract for P-8A Maintenance Services
- Intra-Cellular Therapies Unveils Promising Data on Lumateperone
- Standard Lithium Secures Major Grant Boosting Lithium Production
- Exploring Class 1 Nickel's Dundonald South Project Potential
- Top Meme Coins Selected by Expert Trader Without Dogecoin or Shiba Inu
- BCREA Pushes for Changes to Short-Term Rental Legislation
- Power Rental Market Growth: Future Prospects and Insights
- Taiwan Hackers Accused by China Amid Rising Tensions
- Pasofino Gold Significantly Advances with $75 Million Acquisition Proposal
- Telos Corporation Expands TSA PreCheck Services Across States
- LogicMark: Pioneering Safety Solutions for Independent Seniors
- BIO-key Strengthens Biometric Access with British Columbia
- Insights into CNBC's Final Trades: Key Highlights
- Chestnut Carbon Expands Green Initiatives with New Land Purchase
- Blue Arch Capital Joins Forces with Lincoln and LoanCore for Growth
- COSCIENS Biopharma's Progress on Integration and Future Plans
- Analyst Predictions Show Potential Gains for CrowdStrike Stock
- ISS Endorses Nano Dimension's Strategic Move for Desktop Metal
- Lantern Pharma Secures FDA Designation for Pediatric Cancer Drug
- Stock Market Update: Jin Medical and NIO Lead Pre-Market Decline
- Analysts Spotlight Micron with 92% Upside Potential: Key Picks
- Hitachi Energy Expands North American Manufacturing with $155M
- Revitalizing Automotive Education: A New Era for Technicians
- Maximize Your Earnings with KB Home Stock Dividend Insights
- 22nd Century Group Expands Internationally with New Deals
- Novel Feed Additives: Growth Strategies and Market Trends Ahead
- Trulieve Expands Reach with New Medical Dispensary
- Intapp Rides on Strong Growth Trajectory Following Price Target Boost
- Broadside Enterprises Opens Doors for Food Innovators in Delivery
- Exploring the Growth of the Automotive Ultrasonic Sensors Market
- News Corp's Steady Buy Rating Amid REA Group's Bold Moves
- HSBC Transfers Private Banking Operations to BNP Paribas
- Computer Aided Engineering Market Projection Revealed
- BMO Highlights Growth Potential for Novo Nordisk Amid Trials
- Growth Forecast for Hearing Aid Market Through Technology Enhancements
- Surging Growth in Automotive Sensors Sector Expected by 2032
- Kenvue's Stock Performance: Insights and Market Trends
- Future of Luxury Vehicles: Hyper Car Market Expanding Globally
- Voya Financial's Promising Path Forward: A Strategic Outlook
- Exploring the Future of VoIP Services Market Growth and Trends
- Wayfair Plans $700 Million Offering for Senior Secured Notes
- Constellation Energy's Bright Future in Nuclear Energy Growth
- Global MRO Market for Air Transport Forecast to Hit $130 Billion
- Zenpack Advances Sustainability with New Certifications
- Transform Your Wood Finishing with FinishWorks' Cerus-n-Stain
- MoffettNathanson Rates The Trade Desk Stock as Neutral
- Pacific Foods Partners with Matty Matheson to Embrace Sundays
- Rise of Automotive Gear Oil Market: Forecast to 2034
- Iron Mountain Stock Target Increased Amid Strong Growth
- Transform Your Skin with Ultherapy PRIME: The Future of Aesthetics